en
Scientific article
English

Influence of the preparation method on residual solvents in biodegradable microspheres

Published inInternational journal of pharmaceutics, vol. 131, no. 2, p. 171-181
Publication date1996
Abstract

Spray-drying, the (w/o)w solvent evaporation method and the aerosol solvent extraction system (ASES) were used to study the influence of the preparation method on residual solvents in microspheres. Poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) (75:25) were selected as polymers and methanol, methylene chloride and chloroform were used as solvents to prepare drug-free and tetracosactide (model peptide) loaded microspheres. The residual solvent contents of the microparticles were determined by multiple headspace extraction from the solid samples. In all batches, residual methanol was well below the limit of 1000 ppm (Rabiant, 1991), whereas residual methylene chloride was only well below the USP XXIII limit of 500 ppm in batches prepared by spray drying at an inlet temperature of 60°C. The lowering of the inlet temperature to 50°C led to increased residual methylene chloride concentrations ranging from 300 to 700 ppm. In case of ASES even higher residual methylene chloride contents were obtained. However, when dried under mild conditions (3 days, room temperature, 35 kPa) all batches satisfied the requirements, with the exception of batches containing chloroform (prepared by spray drying at an inlet temperature of 60°C), which could not be efficiently removed. Additionally, morphology, particle size distribution, drug loading and encapsulation efficiencies of the batches prepared by the different methods were studied comparatively.

Keywords
  • Biodegradable microspheres
  • Poly(L-lactic acid)
  • Poly(DL-lactic-co-glycolic acid)
  • Residual solvents
  • Preparation method
  • Multiple headspace extraction
  • Headspace chromatography
Citation (ISO format)
BITZ, Claudia, DOELKER, Eric. Influence of the preparation method on residual solvents in biodegradable microspheres. In: International journal of pharmaceutics, 1996, vol. 131, n° 2, p. 171–181. doi: 10.1016/0378-5173(95)04320-9
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0378-5173
422views
1downloads

Technical informations

Creation07/07/2016 8:31:00 AM
First validation07/07/2016 8:31:00 AM
Update time03/15/2023 12:33:28 AM
Status update03/15/2023 12:33:27 AM
Last indexation01/16/2024 9:19:00 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack